Abstract : A series of methyl [6-(2-aminothiazol-4-yl)-3-oxo-l,4-benzoxazin-2-yl]acetates (3-5) have been synthesized and tested for COX-2 (Cyclooxygenase) / 5-LOX (Lipoxygenase) inhibitory activity. Some of the compounds exhibited notable 5-LOX inhibitory activity.
Introduction
The introduction of Celecoxib and Rofecoxib as antiinflammatory agents with better gastric tolerance has created interest in the development of selective COX-2 inhibitors'. Aminothiazole ring system has broad application in the treatment of allergies 2 , hypertension 3 , inflammation 4 , schizophrenia , bacterial 6 and HIV infections 7 . Fanetizole 4 (4-phenyl-2-phenethylaminothiazole) is an antiinflammatory agent under phase II clinical trials for the treatment of rheumatoid arthritis. Recently, compounds with pyridylaminothiazole as core unit have been reported as anticancer agents 8 , KDR Kinase inhibitors 9 , CNS, mood disorder, brain tumour, epilepsy, anxiety, depression and Alzheimeirs disease 10 . A number of 1,4-benzoxazine derivatives have been reported as 11 19 ι -3 smooth muscle relaxants , anticoagulants and antibacterial agents . Furthermore, several aryl and heteroaryl acetic acids represented by indomethacin, diclofenac, sulindac, fentiazac and Lonazolac enjoy clinical status as antiinflammatory agents'. Prompted by these observations and in continuation of our work on new benzoxazines 14 we report herein the synthesis and COX-2 / 5-LOX inhibitory activity of some new aminothaizolylbenzoxazinyl acetates.
Methyl a-(3,4-dihydro-3-oxo-2H-l,4-benzoxazin-2-yl)acetate (1) required as starting material in the present work, was prepared by the reaction of 2-aminophenol with maleic anhydride in refluxing methanol in the presence of triethylamine according to procedure described earlier 15 . •cm. Η Ο. 
COX-2 / 5-LOX inhibitory activity
All the compounds 3, 4 & 5 ( Table-1 ) were tested for their COX-2 / 5-LOX inhibitory activity. The method of Copeland 16 et. al was adopted for determination of IC50 values as reported earlier. Potato lipoxygenase was used as enzyme source for testing 5-LOX inhibitory activity. The compounds were dissolved in DMSO and stock solution was diluted to required assay concentration. The assay mixture consists of 50 mm phosphate buffer (pH 6.8), the enzyme and the drug at assay concentration in DMSO. The assay mixture was preincubated at 25° and then substrate was added. The enzyme activity was measured by estimating the initial velocity during the first 25 seconds by measuring the absorbance at 235 mm. IC50 values were calculated from four parameter least square nonlinear regression analysis of the log dose vs percentage inhibition plot. Four compounds, amino-3, methylpyridylamino-4b and tolylaminothiazole derivatives 5b & 5c exhibited significant inhibition at 8, 10 & 5 μΜ when compared to standard nor dihydroguairetic acid which inhibited at 1.5 μΜ. Compounds 5a & 5e-h exhibited a low order of activity ranging from 15μΜ-60μΜ (Table-1 ). None of the compounds reported herein exhibited any COX-2 inhibitory activity. 
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Experimental Section
Melting points were determined in open capillaries and are uncorrected. The purity of all the compounds was routinely checked by TLC on silica gel coated plates. IR spectra were recorded on KBr pellets on a Perkin-Elmer 2000 FTIR spectrometer. NMR spectra on a Varian 200 MHz instrument .with TMS as internal standard (chemical shifts in δ ppm) and mass spectra on a Hewelett Packard mass spectrometer operating at 70eV. [6-chloroacetyl-3-oxo-l,4-benzoxazin-2 A mixture of 2 (0.01 mol) and thiourea/pyridylamino thiourea/arylamino thiourea (0.01 mol) in methanol (50 mL) was refluxed for 4-5 hrs. At the end of the reaction as monitored by TLC, solvent was removed in vauo, the residue was treated with NaHC0 3 solution to neutral pH. The separated solid was filtered washed with water, dried and recrystallized from ethylacetate to give pure 3, 4 & 5 as crystalline solids.
Preparation of Methyl
The physical and spectral data of 3, 4 & 5 are listed in Table-1. 
